In addition, Pak et al. found that the positive expression rate of EpCAM protein in tumor tissues of NSCLC patients in stage II-IV was 73.33%, significantly higher than 47.06% in stage I of NSCLC patients 14. The gene discussed is EPCAM; the disease is neoplasm.